| Literature DB >> 22433873 |
Iva Seto1, Michelle Foisy, Brad Arkison, Terry Klassen, Katrina Williams.
Abstract
BACKGROUND: Clinicians are increasingly using electronic sources of evidence to support clinical decision-making; however, there are multiple demands on clinician time, and summarised and synthesised evidence is needed. Clinical Answers (CA) have been developed to address this need; the CA is a synthesised evidence-based summary that supports point-of-care clinical decision-making. The aim of this paper is to report on a survey used to test and improve the CA format.Entities:
Mesh:
Year: 2012 PMID: 22433873 PMCID: PMC3353169 DOI: 10.1186/1471-2431-12-34
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Characteristics of respondents *
| Pediatrician's years in practice (N = 83) | N (%) |
|---|---|
| 0 to 5 | 6 (7.2) |
| 6 to 10 | 19 (22.9) |
| 11 to 15 | 15 (18.1) |
| 16 to 20 | 19 (22.9) |
| 21 to 25 | 7 (8.4) |
| 26 to 30 | 9 (10.8) |
| 31+ | 8 (9.6) |
| Clinical care | 80 (96.4) |
| Research | 46 (55.4) |
| Teaching | 50 (60.2) |
| Other † | 3 (3.6) |
| Cardiology | 0 (0.0) |
| Critical care medicine | 2 (2.5) |
| Emergency medicine | 5 (6.3) |
| Endocrinology | 2 (2.5) |
| Gastroenterology | 0 (0.0) |
| Hematology-oncology | 17 (21.3) |
| Infectious diseases | 6 (7.5) |
| Nephrology | 2 (2.5) |
| Pulmonology/respiratory | 9 (11.3) |
| Rheumatology | 2 (2.5) |
| Sports medicine | 0 (0.0) |
| Neonatology | 3 (3.8) |
| General pediatrics | 22 (27.5) |
| Community/ambulatory | 2 (2.5) |
| Other ‡ | 8 (10.0) |
* Percentages calculated based on number of respondents for each question
§ Respondents could choose more than one answer to this question
† Administration, quality/effectiveness, and 'unknown'
‡ Dermatology, Pediatric Infectious Diseases and Immunology, Allergy-Immunology, Palliative Care, Neurology, Neurodisability, on call, and training
Overall usefulness of the Clinical Answer
| Question | N (%) | ||||
|---|---|---|---|---|---|
| How useful do you find this clinical answer format/approach to presenting evidence? | 0 (0.0) | 1 (1.2) | 5 (6.1) | 39 (47.6) | 37 (45.1) |
| This clinical answer format/approach contains the type of evidence necessary to support clinical decisions. | 0 (0.0) | 4 (4.8) | 6 (7.2) | 40 (48.2) | 33 (39.8) |
| I am likely to make use of these Clinical Answers in the future. | 1 (1.2) | 4 (4.8) | 9 (10.8) | 40 (48.2) | 29 (34.9) |
| I would be likely to make use of this Clinical Answer format instead of a Cochrane Review. | 5 (6.0) | 8 (9.6) | 22 (26.5) | 32 (38.6) | 16 (19.3) |
Level of detail in each section of the Clinical Answer
| How would you describe the level of detail presented in each of the following sections of the Clinical Answer? | |||||||
|---|---|---|---|---|---|---|---|
| Question | 0 (0.0) | 1 (1.2) | 74 (89.1) | 5 (6.0) | 3 (3.6) | 88.9 | 0.04 § |
| Answer | 2 (2.4) | 7 (8.4) | 65 (78.3) | 7 (8.4) | 2 (2.4) | 50.0 | 1.00 |
| Background | 4 (4.8) | 9 (10.8) | 61 (73.5) | 7 (8.4) | 2 (2.4) | 40.9 | 0.52 |
| Search strategy | 3 (3.6) | 6 (7.2) | 58 (69.9) | 12 (14.5) | 4 (4.8) | 64.0 | 0.23 |
| Included reviews | 1 (1.2) | 7 (8.4) | 64 (77.1) | 9 (10.8) | 2 (2.4) | 57.9 | 0.65 |
| Results | 2 (2.4) | 9 (10.8) | 59 (71.1) | 12 (14.5) | 1 (1.2) | 54.2 | 0.84 |
| Limitations | 3 (3.6) | 19 (22.9) | 54 (65.1) | 5 (6.0) | 2 (2.4) | 24.1 | 0.008 † |
| References | 3 (3.6) | 12 (14.5) | 61 (73.5) | 5 (6.0) | 2 (2.4) | 31.8 | 0.13 |
| Linked figures and tables | 0 (0.0) | 2 (2.4) | 62 (74.7) | 15 (18.1) | 4 (4.8) | 90.5 | 0.0002 § |
* Calculated based on whether the proportion of participants that felt there was too much detail (responses '4' and '5') as opposed to too little detail (responses '1' and '2') was significantly different from 50%
§A significant number of respondents thought there was too much detail in this section of the Clinical Answer
†A significant number of respondents thought there was too little detail in this section of the Clinical Answer
^of those who scored 1, 2, 4 or 5
Clinical Answer format
| The table layout of this Clinical Answer is an effective way to present the content. | 0 (0.0) | 5 (6.0) | 10 (12.1) | 41 (49.4) | 27 (32.5) |
| This Clinical Answer format allowed me to quickly locate critical information. | 0 (0.0) | 6 (7.2) | 9 (10.8) | 41 (49.4) | 27 (32.5) |
| Adding GRADE assessments to this Clinical Answer format would greatly enhance the quality of the evidence presented. | 2 (3.7) | 1 (1.9) | 18 (33.3) | 23 (42.6) | 10 (18.5) |
* All participants were asked if they were familiar with the use of GRADE assessments, and only the 54/83 respondents who answered 'yes' were eligible to answer this question
GRADE, Grading of Recommendations Assessment, Development and Evaluation
Net Promoter Score: likelihood of recommending Clinical Answers to colleagues (N = 83)
| How likely would you be to recommend Clinical Answers - similar to the example you reviewed - to a colleague? | ||
|---|---|---|
| 11 (13.2) | ||
| 0 (very unlikely) | 0 (0.0) | |
| 1 | 1 (1.2) | |
| 2 | 0 (0.0) | |
| 3 | 1 (1.2) | |
| 4 | 1 (1.2) | |
| 5 | 0 (0.0) | |
| 6 | 8 (9.64) | |
| 34 (41.0) | ||
| 7 | 14 (16.9) | |
| 8 | 20 (24.1) | |
| 38 (45.8) | ||
| 9 | 15 (18.1) | |
| 10 (very likely) | 23 (27.7) | |
* The NPS is calculated by subtracting Detractors (%) from Promoters (%)